RET Kinase inhibitor 1
| CAS No. | 1627856-64-7 | Cat. No. | BCP23560 |
| Name | RET Kinase inhibitor 1 | ||
| Synonyms | GSK3179106; GSK-3179106; GSK 3179106; | ||
| Formula | C22H21F4N3O4 | M. Wt | 467.41 |
| Description | GSK3179106 is a potent, selective, and gut-restricted pyridone hinge binder small molecule RET kinase inhibitor with a RET IC50 of 0.3 nM and is efficacious in vivo. GSK3179106 is being developed by GlaxoSmithKline for the treatment of irritable bowel syndrome. GSK3179106 showed IC50s of 0.4 and 11 nM in the biochemical assay and cellular assay, respectively. GSK3179106 had a clean genotoxic profile with no embedded genotoxicity liabilities. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | RET | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.